Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

The impact of integrated HIV care on patient health outcomes.

Hoang T, Goetz MB, Yano EM, Rossman B, Anaya HD, Knapp H, Korthuis PT, Henry R, Bowman C, Gifford A, Asch SM.

Med Care. 2009 May;47(5):560-7. doi: 10.1097/MLR.0b013e31819432a0.

2.

Immunologic function and virologic suppression among children with perinatally acquired HIV Infection on highly active antiretroviral therapy.

Rutstein RM, Gebo KA, Flynn PM, Fleishman JA, Sharp VL, Siberry GK, Spector SA.

Med Care. 2005 Sep;43(9 Suppl):III15-22.

PMID:
16116305
3.

Rural residence is associated with delayed care entry and increased mortality among veterans with human immunodeficiency virus infection.

Ohl M, Tate J, Duggal M, Skanderson M, Scotch M, Kaboli P, Vaughan-Sarrazin M, Justice A.

Med Care. 2010 Dec;48(12):1064-70. doi: 10.1097/MLR.0b013e3181ef60c2.

4.

Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa.

Okomo U, Togun T, Oko F, Peterson K, Townend J, Peterson I, Jaye A.

BMC Pediatr. 2012 Jul 8;12:95. doi: 10.1186/1471-2431-12-95.

5.
6.

Reducing barriers to mental health and social services for Iraq and Afghanistan veterans: outcomes of an integrated primary care clinic.

Seal KH, Cohen G, Bertenthal D, Cohen BE, Maguen S, Daley A.

J Gen Intern Med. 2011 Oct;26(10):1160-7. doi: 10.1007/s11606-011-1746-1. Epub 2011 Jun 7.

7.

Surgical outcomes in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.

Horberg MA, Hurley LB, Klein DB, Follansbee SE, Quesenberry C, Flamm JA, Green GM, Luu T.

Arch Surg. 2006 Dec;141(12):1238-45.

PMID:
17178967
8.

Mental health disorders and the risk of AIDS-defining illness and death in HIV-infected veterans.

Nurutdinova D, Chrusciel T, Zeringue A, Scherrer JF, Al-Aly Z, McDonald JR, Overton ET.

AIDS. 2012 Jan 14;26(2):229-34. doi: 10.1097/QAD.0b013e32834e1404.

PMID:
22089375
9.

Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.

Aziz N, Sokoloff A, Kornak J, Leva NV, Mendiola ML, Levison J, Feakins C, Shannon M, Cohan D.

BJOG. 2013 Nov;120(12):1534-47. doi: 10.1111/1471-0528.12226. Epub 2013 Aug 7.

10.

Treatment initiation, program attrition and patient treatment outcomes associated with scale-up and decentralization of HIV care in rural Malawi.

McGuire M, Pinoges L, Kanapathipillai R, Munyenyembe T, Huckabee M, Makombe S, Szumilin E, Heinzelmann A, Pujades-Rodríguez M.

PLoS One. 2012;7(10):e38044. doi: 10.1371/journal.pone.0038044. Epub 2012 Oct 15.

11.

Increasing antiviral treatment through integrated hepatitis C care: a randomized multicenter trial.

Groessl EJ, Sklar M, Cheung RC, Bräu N, Ho SB.

Contemp Clin Trials. 2013 Jul;35(2):97-107. doi: 10.1016/j.cct.2013.05.002. Epub 2013 May 10.

PMID:
23669414
12.

Characteristics of HIV-infected children seen in Western Kenya.

Nyandiko WM, Mwangi A, Ayaya SO, Nabakwe EC, Tenge CN, Gisore PM, Vreeman RC.

East Afr Med J. 2009 Aug;86(8):364-73.

PMID:
20575310
13.

Differences in human immunodeficiency virus care and treatment among subpopulations in the United States.

Hall HI, Frazier EL, Rhodes P, Holtgrave DR, Furlow-Parmley C, Tang T, Gray KM, Cohen SM, Mermin J, Skarbinski J.

JAMA Intern Med. 2013 Jul 22;173(14):1337-44. doi: 10.1001/jamainternmed.2013.6841.

PMID:
23780395
14.

Frequency of HIV-1 viral load monitoring of patients initially successfully treated with combination antiretroviral therapy.

Romih V, Zidovec Lepej S, Gedike K, Lukas D, Begovac J.

PLoS One. 2010 Nov 24;5(11):e15051. doi: 10.1371/journal.pone.0015051.

15.

Comparison of abacavir/lamivudine and tenofovir/emtricitabine among treatment-naive HIV-infected patients initiating therapy.

Tan DH, Chan K, Raboud J, Cooper C, Montaner JS, Walmsley S, Hogg RS, Klein MB, Machouf N, Rourke SB, Tsoukas C, Loutfy MR; CANOC Collaboration.

J Acquir Immune Defic Syndr. 2011 Sep 1;58(1):38-46. doi: 10.1097/QAI.0b013e3182282cfc.

PMID:
21709570
16.

Retention in care: a challenge to survival with HIV infection.

Giordano TP, Gifford AL, White AC Jr, Suarez-Almazor ME, Rabeneck L, Hartman C, Backus LI, Mole LA, Morgan RO.

Clin Infect Dis. 2007 Jun 1;44(11):1493-9. Epub 2007 Apr 23.

17.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
18.
19.

Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report.

Zylberberg H, Benhamou Y, Lagneaux JL, Landau A, Chaix ML, Fontaine H, Bochet M, Poynard T, Katlama C, Pialoux G, Bréchot C, Pol S.

Gut. 2000 Nov;47(5):694-7.

20.

Influence of provider experience on antiretroviral adherence and viral suppression.

Horberg MA, Hurley LB, Towner WJ, Allerton MW, Tang BT, Catz SL, Silverberg MJ, Quesenberry CP.

HIV AIDS (Auckl). 2012;4:125-33. doi: 10.2147/HIV.S35174. Epub 2012 Aug 15.

Items per page

Supplemental Content

Write to the Help Desk